STAVIRAL Trademark

Trademark Overview

On Monday, July 5, 2021, a trademark application was filed for STAVIRAL with the United States Patent and Trademark Office. The USPTO has given the STAVIRAL trademark a serial number of 90811259. The federal status of this trademark filing is ABANDONED - INCOMPLETE RESPONSE as of Thursday, November 2, 2023. This trademark is owned by Suzhou Grit Biotechnology Co., Ltd.. The STAVIRAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
staviral

General Information

Serial Number90811259
Word MarkSTAVIRAL
Filing DateMonday, July 5, 2021
Status600 - ABANDONED - INCOMPLETE RESPONSE
Status DateThursday, November 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Goods and ServicesMedical research; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code042
First Use Anywhere DateSaturday, February 11, 2023
First Use In Commerce DateSaturday, February 11, 2023

Trademark Owner History

Party NameSuzhou Grit Biotechnology Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSangtian St, Suzhou 215000
CN
Party NameSuzhou Grit Biotechnology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSangtian St, Suzhou 215000
CN

Trademark Events

Event DateEvent Description
Thursday, November 2, 2023ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Thursday, November 2, 2023ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Thursday, November 2, 2023ABANDONMENT - INCOMPLETE RESPONSE
Thursday, November 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 2, 2023ASSIGNED TO LIE
Thursday, June 1, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, March 1, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, March 1, 2023FINAL REFUSAL E-MAILED
Wednesday, March 1, 2023SU - FINAL REFUSAL - WRITTEN
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 2, 2022NON-FINAL ACTION E-MAILED
Friday, September 2, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, August 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 10, 2022USE AMENDMENT FILED
Thursday, August 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 10, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Tuesday, September 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 8, 2021NEW APPLICATION ENTERED

Related Keywords

staviral field studies technical research pharmaceutical consulting medical